Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
Coronavirus
As coronavirus concerns grow, Gladstone's virology experts are here to answer your questions, offer insight, provide context, and discuss the impacts of the outbreak on public health.
Gladstone virology experts are available for media interviews.
At Gladstone, we believe that basic science will be key for identifying potential drug targets and creating an effective vaccine. Both are sorely needed. Antivirals that can control coronavirus growth could have a huge impact not only on disease outcome but also on virus transmission from one person to another.
Contact
Julie Langelier
Associate Director, Communications
Direct line: 415.734.5000
Email
Megan McDevitt
Vice President of Communications
Direct line: 415.734.2019
Cell: 404.547.3519
Email
News Releases
1 - 15 of 145 Results
New Antiviral Therapy May Block COVID-19 Transmission
New Antiviral Therapy May Block COVID-19 Transmission
The single-dose, intranasal treatment also reduces symptoms of multiple variants of the SARS-CoV-2 virus
News Release Research (Publication) COVID-19 Center for Cell Circuitry Virology Weinberger Lab ChaturvediWhere Computation and Experimentation Collide
Where Computation and Experimentation Collide
Christina Theodoris joins Gladstone as an assistant investigator to find new therapies for people with life-threatening cardiovascular diseases
Institutional News News Release Profile Cardiovascular Disease Data Science and Biotechnology Theodoris LabRevealing Molecular Switches for Heart Disease
Revealing Molecular Switches for Heart Disease
Michael Alexanian joins Gladstone Institutes to discover new targets for treating and reversing heart failure
Institutional News News Release Profile Heart Failure Cardiovascular Disease Alexanian LabA Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors
A Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors
Scientists develop a new approach that produces enough cells for therapeutic applications
News Release Research (Publication) Genomic Immunology Esensten Lab Eyquem Lab Marson Lab CRISPR/Gene EditingGiving Immunotherapy Cells Resilience to Pass the “Stress Test”
Giving Immunotherapy Cells Resilience to Pass the “Stress Test”
A Gene Not Previously Known to Regulate Immunity Could Turn Tired T-Cells Around
News Release Research (Publication) Cancer Genomic Immunology Carnevale Lab Marson LabScientists Engineer DNA “Receipt Book” to Store Cells’ History
Scientists Engineer DNA “Receipt Book” to Store Cells’ History
Gladstone scientists engineer living biosensors to track the genetic activity of cells
News Release Research (Publication) Data Science and Biotechnology Shipman LabWhat Makes Omicron More Infectious Than Other COVID-19 Variants
What Makes Omicron More Infectious Than Other COVID-19 Variants
Researchers used virus-like particles to identify which mutations of the Omicron SARS-CoV-2 virus make it more effective at infecting cells and escaping antibodies
News Release Research (Publication) COVID-19 Virology Doudna Lab Ott LabBETting On COVID-19: Study Probes Role of BET Proteins in Coronavirus Infection
BETting On COVID-19: Study Probes Role of BET Proteins in Coronavirus Infection
Gladstone researchers find new evidence against using BET inhibitors to treat COVID-19
News Release Research (Publication) COVID-19 Virology Ott LabScientists Map Networks of Disease-Associated Immune Genes
Scientists Map Networks of Disease-Associated Immune Genes
The new immune networks have implications for developing immunotherapies and understanding autoimmune diseases
News Release Research (Publication) Autoimmune Diseases Genomic Immunology Marson LabPathway Deep in the Brain Makes It Resilient after Injury
Pathway Deep in the Brain Makes It Resilient after Injury
Study suggests that targeting a protein in the thalamus could block the long-term damage that follows brain injuries
News Release Research (Publication) Traumatic Brain Injury Neurological Disease Paz LabFinding HIV’s Sweet Spot
Finding HIV’s Sweet Spot
Gladstone scientists uncover novel aspects of HIV infection by monitoring sugars at the surface of individual immune cells
News Release Research (Publication) HIV/AIDS Virology Roan LabThe 2022 Ogawa-Yamanaka Stem Cell Prize Awarded to Juan Carlos Izpisua Belmonte
The 2022 Ogawa-Yamanaka Stem Cell Prize Awarded to Juan Carlos Izpisua Belmonte
Izpisua Belmonte is recognized for his innovative work in programming cellular rejuvenation
Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCsScientists Prevent “Exhaustion” in Cancer-Fighting T Cells
Scientists Prevent “Exhaustion” in Cancer-Fighting T Cells
The new study paves the way toward more effective cancer immunotherapies
News Release Cancer Genomic Immunology Marson Lab“Natural Immunity” from Omicron is Weak and Limited, Study Finds
“Natural Immunity” from Omicron is Weak and Limited, Study Finds
Without vaccination, infection with Omicron fails to confer robust immunity against other COVID-19 variants
News Release Research (Publication) COVID-19 Virology Doudna Lab Ott Lab Roan LabThrowing Drug Resistance for a Loop
Throwing Drug Resistance for a Loop
New class of resistance-proof drugs could one day transform treatments for viral diseases
News Release Research (Publication) Center for Cell Circuitry Virology Weinberger Lab Chaturvedi
